MSX2-WNT SIGNALING IN CARDIOVASCULAR CALCIFICATION
MSX2-WNT SIGNALING IN CARDIOVASCULAR CALCIFICATION
批准号:
8597587
负责人:
DWIGHT A. TOWLER
金额:
$15.14万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-30 至 2014-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Arteriosclerosis is the chronic disease state characterized by thickening and hardening of arterial walls with loss of elasticity. Atherosclerosis, Monckeberg's medial calcific sclerosis, and arteriolosclerosis are the three histopathologic types of arteriosclerosis. With advancing age, impaired glucose tolerance, diabetes, and hypertension, the conduit arteries become increasingly arteriosclerotic, losing compliance necessary for smooth distal tissue perfusion. This Windkessel physiology is impaired by changes in vascular geometry, and by changes in vascular matrix material properties arising from fibrosis, cross-linking and mineralization. Arteriosclerosis- viz., medial calcific sclerosis - has emerged as a particularly important contributor to lower extremity (LE) amputation risk in type II diabetes (T2DM). A better understanding of signaling pathways that control arterial fibrosis, calcification, and compliance will lead to new strategies for diminishing arteriosclerotic disease burden. Recent data identify Wnt/ 2 -catenin signaling and Wnt7 /LRP6 interactions as important in vascular calcification and tissue fibrosis -- down-stream of TNF-, BMP2-, and Msx2- activated osteogenic mineralization. Thus, the specific aims of this proposal are: Aim 1: "To establish the contributions of cell-autonomous vascular smooth muscle cell (VSMC) 2-catenin actions to vascular calcification and mural fibrosis in diabetic arteriosclerosis, using SM22- Cre(+);Ctnnb1(flox/+);LDLR(-/-) mice as a model for study." We test whether genetic down- regulation of VSMC 2-catenin signaling alters initiation and progression of diabetic arteriosclerosis, including diet-induced reductions in LE blood flow in the LDLR-/- mouse. Aim 2: "To examine the role of VSMC LRP6 expression in mediating the pro-calcific actions of Msx2-Wnt signaling during cardiovascular calcification, using diabetic SM22- Cre(+);LRP6(fl/fl);LDLR(-/-) mice as a model for study." LRP6 mediates Wnt7-dependent osteogenic and fibrotic signals in culture via 2-catenin and NFATc-mediated transcription. In this aim, we determine in vivo the cell-autonomous roles of VSMC LRP6 to the initiation of vascular calcification in diabetic arteriosclerosis in vivo, and the impact upon diet-induced activation of aortic osteogenic gene programs. The outcomes of these aims will provide physiological rationale and validation for reducing VSMC 2-catenin levels and LRP6 signaling as a potential therapeutic strategy to ameliorate vascular calcification -- and thus reduce lower extremity amputation risk in type II diabetes
PUBLIC HEALTH RELEVANCE: Arterial hardening in diabetes increases the risk for heart attacks & foot amputation. This occurs in part via metabolic & inflammatory signals that induce bone-like calcification in large arteries. We have identified that two proteins, LRP6 and 2-catenin, are activated with calcification, fibrosis, and hardening of the arteries in diabetic mice. We test whether regulation of these proteins reduces arterial hardening, decreases cardiac workload, and improves blood flow to the foot.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cdc42bpg signaling in arteriosclerosis and vascular fibrosis
-
批准号:10448070
-
项目类别:
-
资助金额:$16.4万
-
财政年份:2022
-
负责人:DWIGHT A. TOWLER
-
依托单位:
University of Texas Southwestern - Stimulating Access to Research in Residency (UT-StARR) Program
-
批准号:10655275
-
项目类别:
-
资助金额:$33.48万
-
财政年份:2021
-
负责人:DWIGHT A. TOWLER
-
依托单位:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
-
批准号:8856647
-
项目类别:
-
资助金额:$39.77万
-
财政年份:2012
-
负责人:DWIGHT A. TOWLER
-
依托单位:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
-
批准号:8597586
-
项目类别:
-
资助金额:$32.84万
-
财政年份:2012
-
负责人:DWIGHT A. TOWLER
-
依托单位:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
-
批准号:8535817
-
项目类别:
-
资助金额:$46.41万
-
财政年份:2012
-
负责人:DWIGHT A. TOWLER
-
依托单位:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
-
批准号:8697129
-
项目类别:
-
资助金额:$47.78万
-
财政年份:2012
-
负责人:DWIGHT A. TOWLER
-
依托单位:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
-
批准号:8352879
-
项目类别:
-
资助金额:$5.16万
-
财政年份:2012
-
负责人:DWIGHT A. TOWLER
-
依托单位:
TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE
-
批准号:7608622
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:DWIGHT A. TOWLER
-
依托单位:
TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE
-
批准号:8020994
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:DWIGHT A. TOWLER
-
依托单位:
TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE
-
批准号:7762246
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:DWIGHT A. TOWLER
-
依托单位:
TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE
-
批准号:7364683
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:DWIGHT A. TOWLER
-
依托单位:
TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE
-
批准号:8217261
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2008
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-Wnt Signaling in Cardiovascular Calcification
-
批准号:7258917
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-WNT SIGNALING IN CARDIOVASCULAR CALCIFICATION
-
批准号:8477231
-
项目类别:
-
资助金额:$45.95万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-Wnt Signaling in Cardiovascular Calcification
-
批准号:7449728
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-Wnt Signaling in Cardiovascular Calcification
-
批准号:7640902
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-WNT SIGNALING IN CARDIOVASCULAR CALCIFICATION
-
批准号:8290230
-
项目类别:
-
资助金额:$22.48万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-Wnt Signaling in Cardiovascular Calcification
-
批准号:7125488
-
项目类别:
-
资助金额:$37.23万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-Wnt Signaling in Cardiovascular Calcification
-
批准号:6944594
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-WNT SIGNALING IN CARDIOVASCULAR CALCIFICATION
-
批准号:7984957
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于“毒瘀互结”理论探讨加味黄芩汤通过miR-3194-5p/CTNNBIP1调节Wnt/β-catenin通路抑制肠癌肝转移的机制研究
-
批准号:2026JJ80966
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曹文
-
依托单位:
Wnt通路介导PD-1调控巨噬细胞极化对高脂血症性急性胰腺炎的影响及机制研究
-
批准号:2026JJ82356
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李想
-
依托单位:
雄激素受体信号与PRP-Exos介导的Wnt/β-catenin通路交互调控毛囊微型化的机制及靶向干预研究
-
批准号:JCZRQNB202600031
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于 Wnt/β-catenin 信号通路探讨张家界杜仲促进骨质疏松性骨折愈合的机制研究
-
批准号:2026JJ80688
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘迎节
-
依托单位:
EGFL7通过负调控WLS/Wnt通路抑制肿瘤增殖及转移的机制研究
-
批准号:2026JJ81240
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李峰
-
依托单位:
基于斑马鱼模型研究DSP突变通过Plakoglobin核转位抑制Wnt通路导致先天缺牙的分子机制
-
批准号:2026JJ81750
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭玲
-
依托单位:
基于Wnt/β-catenin信号通路探讨椎间盘退变髓核细胞-细胞外基质交互机制及补肾活血汤的干预作用
-
批准号:2026JJ81858
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李泽湘
-
依托单位:
基于“祛湿敛疮”理论探讨郁术方通过Wnt/β-catenin通路促进糖尿病溃疡愈合药效成分与作用机制
-
批准号:2026JJ82686
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖望重
-
依托单位:
同源异形盒基因HOXA10异常甲基化调控Wnt4/β-Catenin通路在子宫内膜癌发生发展中的作用研究
-
批准号:JCZRLH202601790
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
EGFL6通过抑制SH3GL2激活Wnt/β-catenin促进胶原沉积导致青年结直肠癌进展的作用机制研究
-
批准号:JCZRLH202601420
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: